VEGFA and neoplasm: Moreover, vascular endothelial growth factor (VEGF)-targeted drugs can affect the tumor microenvironment in NSCLC by inhibiting immune escape, normalizing tumor vasculature, modulating T-cell numbers, and increasing tumor immune cells (83).